Cubist Systematic Strategies’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-202,059
| Closed | -$34.6M | – | 3271 |
|
|
2025
Q2 | $30.9M | Buy |
+202,059
| New | +$31.1M | 0.14% | 163 |
|
|
2025
Q1 | – | Sell |
-73,197
| Closed | -$11.5M | – | 3180 |
|
|
2024
Q4 | $10.6M | Buy |
+73,197
| New | +$11.3M | 0.07% | 439 |
|
|
2024
Q2 | – | Sell |
-210,465
| Closed | -$31.3M | – | 3498 |
|
|
2024
Q1 | $33.3M | Buy |
210,465
+202,930
| +2,693% | +$32.3M | 0.19% | 67 |
|
|
2023
Q4 | $1.18M | Sell |
7,535
-53,324
| -88% | -$8.18M | 0.01% | 1923 |
|
|
2023
Q3 | $9.48M | Buy |
60,859
+57,959
| +1,999% | +$9.56M | 0.07% | 403 |
|
|
2023
Q2 | $480K | Sell |
2,900
-43,727
| -94% | -$7.06M | ﹤0.01% | 2415 |
|
|
2023
Q1 | $7.23M | Buy |
46,627
+23,824
| +104% | +$3.85M | 0.04% | 665 |
|
|
2022
Q4 | $4.03M | Sell |
22,803
-9,733
| -30% | -$1.68M | 0.02% | 1220 |
|
|
2022
Q3 | $5.32M | Sell |
32,536
-40,045
| -55% | -$6.78M | 0.03% | 1022 |
|
|
2022
Q2 | $12.9M | Buy |
72,581
+17,048
| +31% | +$3.04M | 0.08% | 299 |
|
|
2022
Q1 | $9.84M | Sell |
55,533
-2,775
| -5% | -$472K | 0.08% | 306 |
|
|
2021
Q4 | $9.97M | Sell |
58,308
-35,511
| -38% | -$5.81M | 0.09% | 248 |
|
|
2021
Q3 | $15.2M | Sell |
93,819
-41,824
| -31% | -$7.14M | 0.19% | 77 |
|
|
2021
Q2 | $22.3M | Buy |
135,643
+58,603
| +76% | +$9.7M | 0.25% | 36 |
|
|
2021
Q1 | $12.7M | Buy |
77,040
+68,322
| +784% | +$11.1M | 0.16% | 108 |
|
|
2020
Q4 | $1.37M | Sell |
8,718
-49,587
| -85% | -$7.32M | 0.02% | 1174 |
|
|
2020
Q3 | $8.68M | Sell |
58,305
-93,770
| -62% | -$13.9M | 0.13% | 195 |
|
|
2020
Q2 | $21.4M | Buy |
152,075
+60,038
| +65% | +$8.75M | 0.37% | 17 |
|
|
2020
Q1 | $12.1M | Buy |
92,037
+81,449
| +769% | +$11.6M | 0.33% | 44 |
|
|
2019
Q4 | $1.54M | Sell |
10,588
-170,914
| -94% | -$23.2M | 0.03% | 893 |
|
|
2019
Q3 | $23.5M | Sell |
181,502
-25,403
| -12% | -$3.35M | 0.47% | 13 |
|
|
2019
Q2 | $28.8M | Buy |
206,905
+170,030
| +461% | +$23.5M | 0.53% | 7 |
|
|
2019
Q1 | $5.16M | Buy |
36,875
+31,617
| +601% | +$4.24M | 0.17% | 125 |
|
|
2018
Q4 | $679K | Sell |
5,258
-74,824
| -93% | -$10.4M | 0.03% | 771 |
|
|
2018
Q3 | $11.1M | Buy |
80,082
+17,693
| +28% | +$2.35M | 0.6% | 14 |
|
|
2018
Q2 | $7.57M | Buy |
62,389
+47,589
| +322% | +$5.94M | 0.38% | 28 |
|
|
2018
Q1 | $1.9M | Sell |
14,800
-5,845
| -28% | -$790K | 0.11% | 232 |
|
|
2017
Q4 | $2.88M | Sell |
20,645
-27,304
| -57% | -$3.8M | 0.15% | 129 |
|
|
2017
Q3 | $6.23M | Sell |
47,949
-18,594
| -28% | -$2.46M | 0.35% | 23 |
|
|
2017
Q2 | $8.8M | Buy |
66,543
+43,836
| +193% | +$5.59M | 0.56% | 8 |
|
|
2017
Q1 | $2.83M | Buy |
22,707
+1,295
| +6% | +$155K | 0.2% | 87 |
|
|
2016
Q4 | $2.47M | Sell |
21,412
-13,475
| -39% | -$1.56M | 0.2% | 97 |
|
|
2016
Q3 | $4.12M | Buy |
34,887
+12,055
| +53% | +$1.46M | 0.26% | 52 |
|
|
2016
Q2 | $2.77M | Sell |
22,832
-10,139
| -31% | -$1.15M | 0.16% | 125 |
|
|
2016
Q1 | $3.57M | Buy |
32,971
+12,696
| +63% | +$1.31M | 0.2% | 94 |
|
|
2015
Q4 | $2.08M | Buy |
20,275
+5,071
| +33% | +$510K | 0.12% | 214 |
|
|
2015
Q3 | $1.42M | Sell |
15,204
-56,406
| -79% | -$5.46M | 0.07% | 399 |
|
|
2015
Q2 | $6.98M | Sell |
71,610
-4,157
| -5% | -$416K | 0.34% | 33 |
|
|
2015
Q1 | $7.62M | Buy |
75,767
+47,859
| +171% | +$4.87M | 0.37% | 26 |
|
|
2014
Q4 | $2.92M | Sell |
27,908
-8,610
| -24% | -$907K | 0.16% | 141 |
|
|
2014
Q3 | $3.89M | Sell |
36,518
-4,345
| -11% | -$451K | 0.24% | 75 |
|
|
2014
Q2 | $4.28M | Buy |
+40,863
| New | +$4.13M | 0.26% | 68 |
|
Other funds holding JNJ
Cubist Systematic Strategies's JNJ Position: Q3 2025 in Review
Cubist Systematic Strategies sold out of Johnson & Johnson (JNJ) in Q3 2025, closing a stake of 202,059 shares — an estimated $34.6M sold.
Cubist Systematic Strategies first reported a position in JNJ in Q2 2014 and held it in 42 quarters. The position peaked at $33.3M in Q1 2024. 4,187 funds tracked by Wall St. Rank hold JNJ as of Q3 2025.
- Cubist Systematic Strategies reported no remaining Johnson & Johnson position as of Q3 2025 after selling out during the quarter.
- Cubist Systematic Strategies sold 202,059 Johnson & Johnson shares in Q3 2025, an estimated $34.6M.
- Cubist Systematic Strategies first reported a position in Johnson & Johnson in Q2 2014 and held it in 42 quarters.
- Cubist Systematic Strategies's Johnson & Johnson position peaked at $33.3M in Q1 2024.
- 4,187 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2025.
Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.